表紙
市場調査レポート

骨再生:パイプライン製品の分析

Bone Regeneration - Pipeline Review, H2 2014

発行 Global Markets Direct 商品コード 288831
出版日 ページ情報 英文 35 Pages
即納可能
価格
本日の銀行送金レート: 1USD=102.12円で換算しております。
Back to Top
骨再生:パイプライン製品の分析 Bone Regeneration - Pipeline Review, H2 2014
出版日: 2014年09月15日 ページ情報: 英文 35 Pages
概要

骨再生は、骨の修復・骨機能の回復を最適化するための限定的な一時的・空間的シーケンスを持つ数多くの細胞種類および細胞内・細胞外の分子シグナル伝達経路を含めた、骨誘導・伝導の複雑な生物学的事象です。骨再生は、外傷、感染症、腫瘍切除および骨格異常などによって大規模な骨欠損が生じた場合、もしくは虚血壊死、委縮性癒着不能および骨粗しょう症などで損傷した場合の再生プロセスで必要とされます。

当レポートでは、骨再生に対する治療薬の開発状況について調査分析し、パイプライン製品の概要、治験の段階別の製品の概要、主要企業プロファイル、薬剤のプロファイル、パイプライン製品の動向などについて、体系的な情報を提供しています。

目次

イントロダクション

骨再生の概要

治療薬の開発

  • パイプライン製品:概要
  • パイプライン製品:比較分析

開発中の治療薬:企業別

調査中の製品:大学/研究機関別

パイプライン製品の概要

  • 初期段階の製品

開発中の製品:企業別

調査中の製品:大学/研究機関別

治療薬の開発に従事している企業

  • CYATHUS EXQUIRERE PharmaforschungsGmbH
  • GliaMed, Inc.
  • Histocell S.L.
  • Bioventus LLC
  • Samumed

治療薬の評価

  • 単独療法の場合
  • 標的別
  • 作用機序別
  • 投与経路別
  • 分子タイプ別

薬剤のプロファイル

  • WX-04554
  • HR-004
  • 骨修復・再生向けアクティブインターフェロンアルファ5の小分子
  • Chordin
  • Cyathus-1103-B
  • GM-1485
  • 線維芽細胞増殖因子複合体
  • タンパク分屑
  • 整形外科治療用の組み換えタンパク

休止状態のプロジェクト

付録

図表

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: GMDHC5503IDB

Summary

Global Markets Direct's, 'Bone Regeneration - Pipeline Review, H2 2014', provides an overview of the Bone Regeneration's therapeutic pipeline.

This report provides comprehensive information on the therapeutic development for Bone Regeneration, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Bone Regeneration and special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides a snapshot of the global therapeutic landscape of Bone Regeneration
  • The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities
  • The report reviews key players involved in the therapeutics development for Bone Regeneration and enlists all their major and minor projects
  • The report summarizes all the dormant and discontinued pipeline projects
  • A review of the Bone Regeneration products under development by companies and universities/research institutes based on information derived from company and industry-specific sources
  • Pipeline products coverage based on various stages of development ranging from pre-registration till discovery and undisclosed stages
  • A detailed assessment of monotherapy and combination therapy pipeline projects
  • Coverage of the Bone Regeneration pipeline on the basis of target, MoA, route of administration and molecule type
  • Latest news and deals relating related to pipeline products

Reasons to buy

  • Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop strategic initiatives by understanding the focus areas of leading companies
  • Identify and understand important and diverse types of therapeutics under development for Bone Regeneration
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Devise corrective measures for pipeline projects by understanding Bone Regeneration pipeline depth and focus of Indication therapeutics
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Global Markets Direct Report Coverage
  • Bone Regeneration Overview
  • Therapeutics Development
    • Pipeline Products for Bone Regeneration - Overview
    • Pipeline Products for Bone Regeneration - Comparative Analysis
  • Bone Regeneration - Therapeutics under Development by Companies
  • Bone Regeneration - Therapeutics under Investigation by Universities/Institutes
  • Bone Regeneration - Pipeline Products Glance
    • Early Stage Products
  • Bone Regeneration - Products under Development by Companies
  • Bone Regeneration - Products under Investigation by Universities/Institutes
  • Bone Regeneration - Companies Involved in Therapeutics Development
    • CYATHUS EXQUIRERE PharmaforschungsGmbH
    • Histocell S.L.
  • Bone Regeneration - Therapeutics Assessment
    • Assessment by Monotherapy Products
    • Assessment by Target
    • Assessment by Mechanism of Action
    • Assessment by Molecule Type
  • Drug Profiles
    • WX-04554 - Drug Profile
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • HR-004 - Drug Profile
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Drugs to Activate Integrin Alpha 5 for Bone Repair and Bone Regeneration - Drug Profile
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Chordin - Drug Profile
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Cyathus-1103-B - Drug Profile
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Recombinant Erythropoetin For Wounds and Bone Regeneration - Drug Profile
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • HC-016 - Drug Profile
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • LWnt-3a - Drug Profile
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Protein to Activate FGFR for Dermatology, CNS, Cardiovascular and Musculoskeletal Disorders - Drug Profile
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Proteins for CNS, Cardiovascular and Musculoskeletal Disorders - Drug Profile
      • Product Description
      • Mechanism of Action
      • R&D Progress
  • Bone Regeneration - Dormant Projects
  • Appendix
    • Methodology
    • Coverage
    • Secondary Research
    • Primary Research
    • Expert Panel Validation
    • Contact Us
    • Disclaimer

List of Tables

  • Number of Products under Development for Bone Regeneration, H2 2014
  • Number of Products under Development for Bone Regeneration - Comparative Analysis, H2 2014
  • Number of Products under Development by Companies, H2 2014
  • Number of Products under Investigation by Universities/Institutes, H2 2014
  • Comparative Analysis by Early Stage Development, H2 2014
  • Products under Development by Companies, H2 2014
  • Products under Investigation by Universities/Institutes, H2 2014
  • Bone Regeneration - Pipeline by CYATHUS EXQUIRERE PharmaforschungsGmbH, H2 2014
  • Bone Regeneration - Pipeline by Histocell S.L., H2 2014
  • Assessment by Monotherapy Products, H2 2014
  • Number of Products by Stage and Target, H2 2014
  • Number of Products by Stage and Mechanism of Action, H2 2014
  • Number of Products by Stage and Molecule Type, H2 2014
  • Bone Regeneration - Dormant Projects, H2 2014

List of Figures

  • Number of Products under Development for Bone Regeneration, H2 2014
  • Number of Products under Development for Bone Regeneration - Comparative Analysis, H2 2014
  • Number of Products under Investigation by Universities/Institutes, H2 2014
  • Comparative Analysis by Early Stage Products, H2 2014
  • Assessment by Monotherapy Products, H2 2014
  • Number of Products by Top 10 Target, H2 2014
  • Number of Products by Stage and Top 10 Target, H2 2014
  • Number of Products by Top 10 Mechanism of Action, H2 2014
  • Number of Products by Stage and Top 10 Mechanism of Action, H2 2014
  • Number of Products by Top 10 Molecule Type, H2 2014
  • Number of Products by Stage and Top 10 Molecule Type, H2 2014
Back to Top